Not an SEC registrant

Acrotech Biopharma INC.

Customers

1 federal agency, 1 prime contractor

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Federal obligations

$4.1M

FY2023 · USAspending.gov

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Federal contracts 1

Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $4.1M in the latest fiscal year shown per agency.

Agency	Obligated	Fiscal year	Awards	Trend	Largest award
Department of Health and Human Services National Institutes of Health	$4.1M	FY 2023	1		75N93020C00040
ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER Award 75N93020C00040 on USAspending.gov ↗ Largest of 1 awards in FY2023: $4.1M obligated

Federal subcontracts received 1

Prime contractors that subcontracted federal work to this company. From USAspending.gov subaward reports; amounts are as reported by the prime contractor, latest report per subaward, $500K+ a year.

Company	Subawards	Fiscal year	Count	Trend	Largest subaward
Chemonics International, INC.	$74.4M	FY 2025	1		AIDOAATO1500007
THE PURPOSE OF THIS SUBCONTRACT IS TO ENTER INTO AN IDIQ FOR THE SUPPLY OF ARVS MANUFACTURED BY AUROBINDO PHARMA LIMITED AND APL HEALTHCARE LIMITED FOR USE IN MULTIPLE COUNTRIES SUPPORTED BY THE GHSC-PSM PROJECT. Prime award AIDOAATO1500007 on USAspending.gov ↗ Subaward CTR005543: $74.4M · Agency for International Development (USAID)

Alerts are coming

Get an email when Acrotech Biopharma INC.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.